Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial. // Blood. – URL: https://www.sciencedirect.com/science/article/pii/S000649712611787X?dgcid=rss_sd_all
Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial. Blood. https://www.sciencedirect.com/science/article/pii/S000649712611787X?dgcid=rss_sd_all
“Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial.” Blood.
@article{article97533,
title = {Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial},
journal = {Blood},
url = {https://www.sciencedirect.com/science/article/pii/S000649712611787X?dgcid=rss_sd_all}
}